NIH-funded research NIH-funded research

Pilot-Feasibility Pilot for Batten Disease Translational Research

Official title: Pilot-Feasibility

Funded at Hugo W. Moser Res Inst Kennedy Krieger · NIH-11417537 · Data updated 2026-11-12

A small, dedicated funding core will support early, practicalBattten disease projects to speed up diagnosis, care, and potential treatments for children affected by Batten disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionHugo W. Moser Res Inst Kennedy Krieger
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 15, 2025
Project endAugust 31, 2030
Funding year2026
Award (this year)$116,149
NIH project number5U54HD122210-02
Project IDNIH-11417537 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include pediatric patients with Batten disease or their families, and researchers with proposed translational or clinical pilot studies relevant to Batten disease.

Less likely to help

Patients not directly connected to Batten disease or without eligible pilot projects may not experience direct benefit.

What this research studies

This grant funds a Pilot Study Core within the Batten Disease Clinical Research Consortium to identify and fund short, high-potential translational and clinical pilot studies. The program emphasizes a patient-centric approach, collaboration across stakeholders, and a rigorous NIH-style review to select projects aligned with community priorities. By supporting early-stage ideas from both new and established researchers, the core aims to build clinical trial readiness and address critical needs in Batten disease care. Results could pave the way for larger studies and improved management for children and families affected by Batten disease.

Why it matters

Potential benefit: If successful, this core could accelerate new diagnostic tools, treatments, and better care strategies for Batten disease patients.

How similar studies have gone: The pilot-study approach has been used in other rare diseases to rapidly advance promising ideas toward clinical testing.

Where this research is happening

  • Hugo W. Moser Res Inst Kennedy Krieger
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Thio, Kwee Liu Lin — Hugo W. Moser Res Inst Kennedy Krieger
  • Study coordinator: Thio, Kwee Liu Lin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.